NCT06243913 (BIOKIBANK) is a clinical trial of IUI with vitrified sperm from donor: in Infertility, sponsored by Clínica EUGIN.

Who is sponsoring NCT06243913?

NCT06243913 is sponsored by Clínica EUGIN.

What drugs are being tested in NCT06243913?

Interventions in NCT06243913: IUI with vitrified sperm from donor:.

What condition does NCT06243913 study?

NCT06243913 studies Infertility.

Is NCT06243913 still recruiting?

NCT06243913 is currently completed. Last updated 18 December 2024.

Last reviewed 2024-12-18 · How we verify

NCT06243913: BIOKIBANK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pilot Study Analyzing Reproductive Results After IUI Using Vitrified Human Sperm

Completed Last updated 18 December 2024

What this trial tests

trial testing IUI with vitrified sperm from donor: in Infertility in 30 participants. Completed in 13 December 2024.

Timeline

20 December 2022

Primary endpoint
13 December 2024

13 December 2024

Quick facts

Lead sponsor	Clínica EUGIN
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	20 December 2022
Primary completion	13 December 2024
Estimated completion	13 December 2024
Sites	1 location across Spain

Drugs / interventions tested

IUI with vitrified sperm from donor:

Conditions studied

Infertility — all drugs for Infertility →

Sponsor

Clínica EUGIN

Who can join

Adults 18 to 35, any sex, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the evaluate the effectiveness of vitrified donor semen in intrauterine insemination treatments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting

Other Clínica EUGIN trials

Trials by the same sponsor.

NCT05109403 — Ovarian Response in Oocyte Donors Triggered With GnRH Agonists · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06243913 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clínica EUGIN
Last refreshed: 18 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06243913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing